Metabolomics identifies riboflavin as a therapeutic agent for acute pancreatitis.

Acute pancreatitis (AP) is a self-limiting inflammatory disorder, but severe cases can lead to persistent organ failure with high mortality. Metabolic dysregulation and inflammatory activation play critical roles in AP pathogenesis, highlighting the…

Preview only. Read the full abstract at the source